iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 2,740.00
-40.00 (-1.44%)
Aug 12, 2026, 1:01 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 85.88 billion as of August 11, 2026. Its market cap has decreased by -33.26% in one year.
Market Cap
85.88B
Enterprise Value
47.46B
Revenue
5.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,740.00
ChartMarket Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has decreased from 95.30B to 85.88B, a decrease of -9.88%. That is a compound annual growth rate of -0.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 85.88B | -16.42% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 133.57B |
| Genexine | 123.70B |
| Vaxcell-Bio Therapeutics | 96.98B |
| MedPacto | 94.94B |
| Prestige BioPharma | 79.33B |
| CG Invites | 76.43B |
| Amicogen | 72.14B |
| ENCell | 68.05B |